Understanding Statistical Significance
P-values and sample sizes are critical for evaluating peptide research quality. A p-value less than 0.05 typically indicates statistical significance, but this doesn't automatically mean clinical relevance.
Sample Size Matters
Small studies (n<20) may show dramatic effects but lack statistical power. Larger studies (n>100) provide more reliable results. Many peptide studies suffer from inadequate sample sizes, making results preliminary at best.
Effect Size vs Statistical Significance
A study might show statistically significant results (p<0.05) but clinically insignificant effect sizes. For example, a 2% improvement might be statistically significant in a large study but practically meaningless.
Common Red Flags
P-hacking: Multiple comparisons without correction inflate significance
Cherry-picking: Reporting only positive subgroups
Underpowered studies: Too few subjects to detect meaningful effects
Missing controls: Lack of proper placebo or control groups
Practical Application
When reviewing peptide research, look for adequate sample sizes, appropriate statistical methods, confidence intervals (not just p-values), and replication by independent researchers. Be especially cautious of single studies with dramatic claims.
Critical Evaluation
Consider the funding source, publication bias, and whether results have been replicated. Many promising peptide studies fail to translate when subjected to larger, more rigorous trials.
This information is for research purposes only and not medical advice.